NCT01785615View on ClinicalTrials.gov

Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2011

Study Completion Date

May 31, 2013

Conditions
Metabolic Syndrome
Interventions
DRUG

Atorvastatin

80mg

OTHER

Placebo

80mg

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Rochester

OTHER